Edgar Lomax CO Johnson & Johnson Transaction History

Edgar Lomax CO

$1.63 Billion
Q3 2024

A detailed history of Edgar Lomax CO transactions in Johnson & Johnson stock. As of the latest transaction made, Edgar Lomax CO holds 204,640 shares of JNJ stock, worth $29.8 Million. This represents 2.04% of its overall portfolio holdings.

Number of Shares

204,640

Previous 207,840 1.54%

Holding current value

$29.8 Million

Previous $30.4 Million 9.17%

% of portfolio

2.04%

Previous 1.98%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $465,535 - $535,616	-3,200 Reduced 1.54%	204,640 $33.2 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $380,441 - $415,750	-2,635 Reduced 1.25%	207,840 $30.4 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $17.5 Million - $18.3 Million	112,608 Added 115.06%	210,475 $33.3 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $643,552 - $702,249	-4,420 Reduced 4.32%	97,867 $15.3 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $290,473 - $325,405	-1,865 Reduced 1.79%	102,287 $15.9 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $218,868 - $235,543	-1,418 Reduced 1.34%	104,152 $17.2 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $9.52 Million - $11.4 Million	-63,005 Reduced 37.38%	105,570 $16.4 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $152,190 - $170,800	-950 Reduced 0.56%	168,575 $29.8 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $153,263 - $170,544	-950 Reduced 0.56%	169,525 $27.7 Million
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $794,697 - $878,897	4,725 Added 2.85%	170,475 $30.3 Million
Q1 2022 May 13, 2022	SELL	$158.14 - $179.59 $8.83 Million - $10 Million	-55,850 Reduced 25.2%	165,750 $29.4 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $314,978 - $349,480	-2,020 Reduced 0.9%	221,600 $37.9 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $356,107 - $395,731	-2,205 Reduced 0.98%	223,620 $36.1 Million
Q2 2021 Aug 09, 2021	SELL	$159.48 - $171.07 $960,866 - $1.03 Million	-6,025 Reduced 2.6%	225,825 $37.2 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $35.5 Million - $39.5 Million	231,850 New	231,850 $38.1 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $16.6 Million - $18.4 Million	-131,879 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $294,816 - $354,816	-2,400 Reduced 1.79%	131,879 $17 Million
Q3 2018 Nov 14, 2018	SELL	$121.58 - $142.88 $595,742 - $700,112	-4,900 Reduced 3.52%	134,279 $18.6 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $111,639 - $123,195	935 Added 0.68%	139,179 $16.9 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $3.82 Million - $4.52 Million	30,500 Added 28.31%	138,244 $17.7 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $419,904 - $459,584	-3,200 Reduced 2.88%	107,744 $15.1 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $14.4 Million - $15 Million	110,944	110,944 $14.4 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgar Lomax CO, based on Form 13F filings with the SEC.

News

Stay updated on Edgar Lomax CO with notifications on news.

Account